MYMD — Mymd Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $5.18m
- -$3.29m
Annual cashflow statement for Mymd Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | -3.89 | -12.2 | -29.9 | -15.2 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.43 | 0.919 | -0.624 | 15.6 | 0.698 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.685 | -0.18 | 0.822 | -5.18 | 2.23 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.5 | -3.07 | -11.9 | -19.5 | -12.3 |
| Capital Expenditures | -0.068 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.291 | -3.94 | -8.76 | 19.9 | 6.91 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.36 | -3.94 | -8.76 | 19.9 | 6.91 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.11 | 6.97 | 38.7 | 0.074 | 5.55 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.243 | -0.049 | 18 | 0.408 | 0.193 |